Eli Lilly reaches $2.75 billion deal with Insilico to bring AI-developed drugs to the global market - CNBC

Eli Lilly reaches $2.75 billion deal with Insilico to bring AI-developed drugs to the global market  CNBCAI drug developer Insilico Medicine and Lilly ink commercialization deal worth up to $2.75 billion  statnews.comInsilico Medicine secures $2.75 billion drug collaboration with Eli Lilly  ReutersEli Lilly to sign $2bn deal for AI drug development with Hong Kong biotech  Financial TimesLilly, Insilico Ink Deal on AI Drugs Worth Up to $2.75 Billion  Bloomberg.com